TīmeklisAndreas M. Ganzoni, MD, is a physician and researcher in the internal medicine department at the University of Zurich in Zurich, Switzerland. Dr. Ganzoni’s primary research is focused on iron deficiency and plasma iron transport. To view Dr. Andreas M. Ganzoni's publications, visit PubMed. Are you Dr. Andreas M. Ganzoni? TīmeklisAbstract. We assessed the clinical response and side effects of Ferrous sulfate (FS) and Iron polymaltose complex (IPC) in 118 children with Iron deficiency anemia (IDA). Subjects were randomized to receive therapy with either oral IPC (Group A, n=59) or oral FS (Group B, n=59); all were given elemental iron in three divided doses of 6 …
Quantitative Spectrophotometric Determinations of Fe
Tīmeklis2014. gada 4. marts · Current treatment strategy for IDA involves the oral use of Fe2+ salts (Fe SO4) and Fe3+ polymaltose complexes (FeOH3). Most of these preparations vary in their bioavailability, efficacy, side effects, and cost. Animal studies have not shown any significant difference in their oral bioavailability. Tīmeklis1984. gada 1. febr. · The bioavailability of iron on Fe(III)-hydroxide-polymaltose complex was compared intraindividually with that of Fe (II)-ascorbate (iron absorption) and a Fe (II)-sulphate quick release ... csp services inc
Pharmacokinetics and red cell utilization of - Wiley Online Library
TīmeklisFe overload eg, haemochromatosis, haemosiderosis; Fe utilisation disturbances eg, lead & sideroachrestic anaemia, thalassaemia; anaemia not caused by Fe deficiency eg, haemolytic or megaloblastic anaemia due to vit B 12 deficiency. Click to view Maltofer detailed prescribing information. TīmeklisN2 - Thirty chronic kidney disease (CKD) patients were retrospectively analysed at the Flinders Medical Centre, having received both iron polymaltose (IP) and ferric carboxymaltose (FCM) iron infusion therapies using an established iron dosing protocol for renal anaemia in CKD. The dose of iron was 500 mg administered intravenously. TīmeklisOur results indicate that, Fe-OH-PM and Fe-Zn preparations may also be preferred as a choice like Fe-S for treatment of children with IDA. Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia. Minerva Pediatr. csp service playbook